Premium
Complications associated with transcatheter closure of perimembranous ventricular septal defects
Author(s) -
Zhou Tao,
Shen XiangQian,
Zhou ShengHua,
Fang ZhenFei,
Hu XinQun,
Zhao YanShu,
Qi ShuShan,
Li Jiang,
Lv XiaoLin
Publication year - 2008
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.21412
Subject(s) - medicine , surgery , atrioventricular block , infective endocarditis , pseudoaneurysm , embolization , fistula , cardiac catheterization , heart block , endocarditis , arteriovenous fistula , cardiology , complication , electrocardiography
Objectives : To identify the complications associated with transcatheter closure of perimembranous ventricular septal defects (PmVSD) using the Amplazter PmVSD occluder (AGA Medical, USA). Methods : Between October 2002 and November 2006, transcatheter closure PmVSD was attempted in 210 patients and performed in 206 patients. Those patients were followed‐up for 6–24 months (mean, 10.6 ± 3.9 months) to identify the complications. Results : Device implantation was successfully accomplished in 206 of the 210 patients (98%). Serious complications such as high degree atrioventricular block (AV block), infective endocarditis, and device embolization occurred in eight cases (3.8%). Other complications including mild aortic or tricuspid regurgitation, femoral pseudoaneurysm, and femoral arteriovenous fistula occurred in four cases. Conclusions : Transcathter closure of PmVSD can be performed safely and successfully. But further studies should continue to evaluate the potential complications associated with this procedure. © 2008 Wiley‐Liss, Inc.